THORENS 25 000 I.U. /2.5 ml oral solution
*Company:
Galen Pharma Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 23 January 2023
File name
05-2.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 01 December 2020
File name
05-2.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 16 September 2020
File name
05-2.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 16 September 2020
File name
05-3.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 16 September 2020
File name
05-3.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 06 June 2019
File name
Thorens 25000.pdf
Reasons for updating
- Change to section 6 - date of revision
- Removal/change of distributor
Updated on 09 October 2018
File name
ie-spc-thorens-25000.pdf
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 9 of the THORENS 25 000 I.U. /2.5ml oral solution Summary of Product Characteristics has been updated to add in the date of last renewal.
Updated on 01 August 2018
File name
Thorens 25000 PIL.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - use in children and adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - how to report a side effect
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 01 August 2018
File name
thorens 25000 compressed.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 5.3 - Preclinical safety data
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
.
Updated on 01 August 2018
File name
thorens 25000 compressed.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 5.3 - Preclinical safety data
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
.
Updated on 29 June 2015
File name
PIL_16387_515.pdf
Reasons for updating
- New PIL for new product
Updated on 29 June 2015
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Galen Pharma Ireland Limited
Address:
Finnabair Industrial Estate, Dundalk, Co Louth IrelandMedical Information E-mail:
customer.services@galen-pharma.comTelephone:
+44 (0)28 3833 4974Fax:
+44 (0)28 3835 0206Website:
https://www.galen-pharma.com